Berachain vs Mira — how do they compare? Berachain trades at Rp2,522 (market cap Rp807,05M, Rp239,46M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Berachain is far larger — about 3.6× Mira's market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Berachain's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Berachain for 16 Days and Mira for 22 Days on average.
| BERA | MIRA | |
|---|---|---|
Market Cap | Rp807,05M | Rp224,51M |
Volume (24h) | Rp239,46M | Rp102,44M |
Circulating Supply | 317,1M BERA | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 16 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Berachain (BERA) is currently trading at Rp2,533 with a market cap of Rp804.4M, showing bearish technical signals across most indicators. The token faces significant selling pressure with moving averages indicating strong bearish momentum while oscillators remain neutral. Current price sits near the pivot point of Rp2,530 with immediate support at Rp2,494 and resistance at Rp2,572. Hold time of 16 days suggests relatively short-term holding patterns among investors.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential bounce from support levels, while major risks include continued selling pressure and limited fundamental developments. Investors should monitor for any ecosystem updates that could change the token's utility and adoption trajectory.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Berachain's PoL mechanism changes L1 economics by creating a marketplace for validators, users, and apps. Validators stake BERA to secure the network and earn BGT rewards, which they can use for application rewards. This system helps scale chain rewards based on demand for security and liquidity.
Read more on BERA →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →